10.1002/ejoc.201700603
European Journal of Organic Chemistry
FULL PAPER
starting materials are solid then we can use minimum amount of solvent
to dissolve it (Toluene, CHCl3 etc.)]
(Z)-N-((Z)-3-benzyl-4-cyclohexyl-5-hexylidenethiazolidin-2-ylidene)-
4-chloroaniline (4f): Viscous oil; Yield 219 mg (94%); IR (neat):
νmax/cm-1 3029, 2926, 2853, 1619, 1584, 1486, 1452, 1409, 1355, 1292,
1230, 1149, 1089, 1029, 1010, 833, 699; 1H NMR (400 MHz, CDCl3) δ
7.40 - 7.18 (m, 7 H), 6.95 10 - 6.84 (m, 2 H), 5.40 (d, J = 15.4 Hz, 1 H),
5.37 - 5.32 (m, 1 H), 4.25 (d, J = 15.4 Hz, 1 H), 4.05 - 3.96 (m, 1 H), 2.09
- 1.86 (m, 2 H), 1.84 - 1.72 (m, 4 H), 1.68 – 1.62 (m, 1 H), 1.48 - 1.21 (m,
9 H), 1.18 - 1.01 (m, 3 H), 0.88 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz,
CDCl3) δ 157.8, 150.40, 137.2, 130.0, 128.9, 128.7, 128.2, 127.9, 127.5,
123.8, 123.7, 69.5, 47.9, 41.7, 31.5, 31.25, 29.0, 28.7, 26.7, 26.6, 26.5,
26.4, 22.5, 14.2; HRMS (ESI) m/z calcd. for C28H35 35ClN2S [M + H]+
467.2288, found 467.2283, m/z calcd. for C28H35 37ClN2S [M + H]+
469.2258, found 467.2274.
(Z)-N-((Z)-3-benzyl-5-benzylidene-4-phenylthiazolidin-2-ylidene)
aniline (4a): White solid; Yield 211 mg (98%); mp 90 - 100 °C
(recrystallized in methanol); IR (neat): νmax/cm-1 3060, 3028, 2953,
2925, 2866, 1639, 1617, 1589, 1491, 1454, 1400, 1356, 1273, 1216,
1193, 1072, 1028, 772, 696; 1H NMR (400 MHz, CDCl3) δ 7.52 - 7.25 (m,
14 H), 7.19 - 7.15 (m, 6 H), 6.25 (s, 1 H), 5.59 (d, J = 15.1 Hz, 1 H), 5.37
(s, 1 H), 3.81 (d, J = 15.1 Hz, 1 H); 13C NMR 8 (125 MHz, CDCl3) 155.8,
151.3, 140.0, 136.6, 135.8, 133.7, 129.2, 129.2, 128.8, 128.7, 128.6 (2C),
128.5, 128.0, 127.7, 127.1, 123.4, 122.6, 122.3, 70.3, 47.5; HRMS (ESI)
m/z calcd. for C29H24N2S [M + H]+ 433.1738, found 433.1731.
(Z)-N-((Z)-3-benzyl-4-cyclohexyl-5-hexylidenethiazolidin-2-ylidene)-
1-phenylmethanamine (4g): Viscous oil; Yield 206 mg (93%); IR (neat):
νmax/cm-1 3062, 3027, 2926, 2853, 1632, 1583, 1494, 1451, 1401, 1347,
(Z)-N-((Z)-3-benzyl-5-heptylidene-4-phenylthiazolidin-2-ylidene)cyc
lopropanamine (4b): Viscous oil; Yield 189 mg (94%); IR (neat):
νmax/cm-1 3085, 3063, 3028, 3005, 2955, 2926, 2855, 1697, 16331494,
1454, 1385, 1265, 1192, 1076, 974, 700; 1H NMR (500 MHz, CDCl3) δ
7.38 - 7.19 (m, 8 H), 7.12 (d, J = 6.8 Hz, 2 H), 5.24 (d, J = 15.2 Hz, 1 H),
5.14 (td, J = 7.2, 1.7 Hz, 1 H) 4.98 (s, 1 H), 3.53 (d, J = 15.2 Hz, 1 H),
2.72 (dt, J = 7.1, 3.5 Hz, 1 H), 2.05 - 1.92 (m, 2 H), 1.30 - 1.18 (m, 8 H),
0.85 (t, J = 7.0 Hz, 3 H), 0.78 (dd, J = 7.2, 2.8 Hz, 2 H), 0.72 -0.63 (m, 2
H); 13C NMR (125 MHz, CDCl3) δ 157.9, 140.5, 137.1, 133.7, 128.9,
128.6, 128.5, 128.3, 127.6, 127.3, 123.0, 68.2, 47.2, 35.6, 31.7, 31.4,
28.9, 28.7, 22.6, 14.1, 7.6, 7.5; HRMS (ESI) m/z calcd. for C26H33N2S [M
+ H]+ 405.2364, found 405.2361.
1
1296, 1193, 1077, 1028, 952, 892, 728, 697; H NMR (400 MHz, CDCl3)
δ 7.41 -7.17 (m, 10 H), 5.48 - 5.32 (m, 2 H), 4.62 - 4.42 (m, 2 H), 4.21 (d,
J = 15.8 Hz, 1 H), 4.05 - 3.93 (m, 1 H), 2.23 - 1.98 (m, 2 H), 1.88 - 1.66
(m, 5 H), 1.53 - 1.42 (m, 3 H), 1.41 - 1.30 (m, 5 H), 1.26 (t, J = 9.5 Hz, 2
H), 1.19 - 1.08 (m, 3 H), 0.94 (t, J = 6.8 Hz, 3 H); 13C NMR (100 MHz,
CDCl3) δ 157.5, 141.4, 137.9, 130.5, 128.5, 128.2, 127.8, 127.3, 127.1,
126.3, 123.1, 69.1, 58.2, 47.9, 41.8, 31.5, 31.3, 29.0, 28.7, 26.7, 26.7,
26.6, 26.4, 22.6, 14.2; HRMS (ESI) m/z calcd. for C29H38N2S [M + H]+
447.2834, found 447.2831.
(Z)-N-((Z)-3-benzyl-4-cyclohexyl-5-hexylidenethiazolidin-2-ylidene)
prop-2-en-1-amine (4h): Viscous oil; Yield 177 mg (90%); IR (neat):
νmax/cm-1 3027, 2926, 2854, 1629, 1494, 1452, 1400, 1324, 1231, 1077,
1029, 993, 699; 1H NMR (500 MHz, CDCl3) δ 7.36 - 7.15 (m, 5 H), 6.02 -
5.88 (m, 1 H), 5.39 - 5.28 (m, 2 H), 5.21 (d, J = 17.1 Hz, 1 H), 5.05 (d, J =
10.3 Hz, 1 H), 4.15 (d, J = 16.0 Hz, 1 H), 3.97 - 3.83 (m, 3 H), 2.17 - 1.95
(m, 3 H), 1.82 -1.59 (m, 6 H), 1.43 (br. s., 3 H), 1.33 (br. s., 5 H), 1.21 (t,
J = 9.1 Hz, 2 H) 1.14 – 0.98 (m, 3 H) 0.91 (t, J = 6.3 Hz, 3 H); 13C NMR
(125 MHz, CDCl3) δ 157.3, 137.7, 136.9, 130.5, 128.40, 127.6, 127.0,
122.8, 114.2, 68.9, 56.7, 47.7, 41.6, 31.4, 31.15, 28.9, 28.6, 26.56, 26.4,
26.3, 22.4, 14.1; HRMS (ESI) m/z calcd. for C25H36N2S [M + H]+ 397.2677,
found 397.2670.
(E)-N-((Z)-3-benzyl-5-benzylidene-4-phenylthiazolidin-2-ylidene)-1-
phenylmethanamine (4c): White solid; Yield 216 mg (97%); mp 100 -
110 °C (recrystallized in methanol); IR (neat): νmax/cm-1 3059, 3026,
2921, 1647, 1619, 1582, 1492, 1452, 1390, 1345, 1270, 1192, 1076,
1
1027, 817, 729, 695; H NMR (500 MHz, CDCl3) δ 7.53 - 7.24 (m, 20 H),
6.29 (s, 1 H), 5.52 (d, J = 15.1 Hz, 1 H), 5.32 (s, 1 H), 4.82 - 4.67 (m, 2
H), 3.75 (d, J = 15.1 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 155.9, 141.1,
140.3, 137.0, 136.0, 133.8, 131.8 (2C), 129.1 (2C), 128.6, 128.5, 128.3,
128.1, 127.6, 127.4, 127.1, 126.6, 122.4, 70.2, 58.2, 47.4; HRMS (ESI)
m/z calcd. for C30H26N2S [M + H]+ 447.1895, found 447.1893.
(Z)-N-((Z)-3-benzyl-5-benzylidene-4-phenylthiazolidin-2-ylidene)prop-
2-en-1-amine (4d): Viscous oil; Yield 184 mg (93%); IR (neat): νmax/cm-
1 3060, 3027, 2919, 1648, 1636, 1618, 1542, 1492, 1454, 1389, 1326,
(Z)-N-((Z)-3-benzyl-4-cyclohexyl-5-hexylidenethiazolidin-2-ylidene)
cyclopropanamine (4i): Viscous oil; Yield 178 mg (90%); IR (neat):
νmax/cm-1 3085, 3004, 2926, 2853, 1698, 1631, 1494, 1451, 1402, 1354,
1290, 1233, 1192, 1030, 721, 699; 1H NMR (500 MHz, CDCl3) δ 7.32 -
7.26 (m, 2 H), 7.25 - 7.19 (m, 3 H), 5.32 (t, J = 7.2 Hz, 1 H), 5.22 (d, J =
15.2 Hz, 1 H), 4.06 (d, J = 15.3 Hz, 1 H), 3.89 (br. s., 1 H), 2.63 - 2.58 (m,
1 H), 2.17 - 2.00 (m, 2 H), 1.74 (br. s., 2 H), 1.67 – 1.60 (m, J = 11.6 Hz,
3 H), 1.42 - 140 (m, 3 H), 1.35 - 1.28 (m, 4 H), 1.20 (t, J = 9.4 Hz, 2 H),
1.12 - 1.03 (m, 3 H), 0.91 (t, J = 6.9 Hz, 3 H), 0.72 - 0.65 (m, 2 H), 0.59 -
0.54 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 159.2, 137.6, 130.9, 128.4
(2C), 127.7 (2C), 127.1 (2C), 122.7, 68.9, 47.7, 41.6, 35.2, 31.4, 31.2,
28.8, 28.7, 26.6, 26.6, 26.5, 26.3, 22.5, 14.1, 7.4, 7.3; HRMS (ESI) m/z
calcd. for C25H36N2S [M + H]+ 397.2677, found 397.2672.
1
1194, 1076, 999, 697; H NMR (400 MHz, CDCl3) δ 7.47 -7.39 (m, 3 H),
7.38 -7.28 (m, 9 H), 7.24 – 7.19 (m, 3 H), 6.27 (s, 1 H), 6.20 - 6.08 (m, 1
H), 5.47 (d, J = 15.1 Hz, 1 H), 5.41 (d, J = 17.4 Hz, 1 H), 5.27 (s, 1 H),
5.21 (d, J = 10.5 Hz, 1 H), 4.24 - 4.07 (m, 2 H), 3.72 (d, J = 15.1 Hz, 1 H);
13C NMR (125 MHz, CDCl3) δ 155.9, 140.2, 136.9, 136.7, 135.9, 133.7,
129.0, 128.6 (2C), 128.5, 128.5, 128.4, 128.0, 127.5, 127.4, 127.1, 122.2,
114.7, 70.2, 56.8, 47.2; HRMS (ESI) m/z calcd. for C26H24N2S [M + H]+
397; 1738, found 397.1733.
(Z)-N-((Z)-3-benzyl-4-cyclohexyl-5-hexylidenethiazolidin-2-ylidene)-
4-ethylaniline (4e): Viscous oil; Yield 209 mg (91%); IR (neat):
νmax/cm-1 3029, 2927, 2854, 1685, 1496, 1435, 1354, 1029, 710; 1H
NMR (500 MHz, CDCl3) δ 7.38 - 7.30 (m, 4 H), 7.28 -7.26 (m, 1 H), 7.11
– 7.01 (m, 2 H), 6.95 - 6.85 (m, 2 H), 5.43 (d, J = 15.4 Hz, 1 H), 5.32 (td,
J = 7.2, 1.7 Hz, 1 H), 4.23 (d, J = 15.4 Hz, 1 H), 3.99 (br. s., 1 H), 2.62 (q,
J = 7.7 Hz, 2 H), 2.07 - 1.88 (m, 2 H), 1.76 (br. s., 4 H), 1.68 (br. s., 1 H),
1.40 -1.18 (m, 11 H) 1.11 (d, J = 9.5 Hz, 2 H), 0.93 -0.81 (m, 3 H); 13C
NMR (100 MHz, CDCl3) δ 157.4, 149.4, 138.9, 137.5, 130.5, 128.7,
128.3, 128.0, 127.4, 123.3, 122.2, 69.4, 48.0, 41.8, 31.5, 31.2, 29.0, 28.8,
28.4, 26.7, 26.6, 26.6, 26.5, 22.6, 15.7, 14.2; HRMS (ESI) m/z calcd. for
C30H40N2S [M + H]+ 461.2990, found 461.2982.
(Z)-N-((Z)-3-benzyl-5-hexylidene-4-phenylthiazolidin-2ylidene)aniline
(4j): Viscous oil; Yield 200 mg (94%); IR (neat): νmax/cm-1 3062, 2955,
2930, 2858, 1602, 1493, 1453, 1072, 732, 698; 1H NMR (500 MHz,
CDCl3) δ 7.46 - 7.22 (m, 12H), 7.18 - 6.99 (m, 3H), 5.47 (d, J = 14.9 Hz,
1H), 5.15 (td, J = 7.0, 1.8 Hz, 1H), 5.10 (d, J = 1.8 Hz, 1H), 3.68 (d, J =
15.3 Hz, 1H), 1.95 - 1.77 (m, 2H), 1.29 - 1.06 (m, 6H), 0.80 (t, J = 7.2 Hz,
3H); 13C NMR (125 MHz, CDCl3) δ 156.4, 151.7, 140.2, 136.6, 133.1,
128.9 (2C), 128.5, 128.5, 128.4, 127.5, 127.4, 123.4, 123.2, 122.3, 68.3,
47.3, 31.2, 31.2, 26.3, 22.3, 13.9; HRMS (ESI) m/z calcd. for C28H30N2S
(M+H) 427.2208; found 427.2200.
This article is protected by copyright. All rights reserved.